FDA Investigator Rebecca E Sulpacio
Rebecca E Sulpacio has inspections in 1 countries as of 21 Aug 2023. Rebecca E Sulpacio has collaborated with a combined 1117 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
21 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abha R Bommireddi,
Alex G Kalugin,
Andrew E Kay,
Angel K Sandhu,
Anna L Marroquin,
Ashar P Parikh,
Baker,
Belinda E Clifton,
Breena L D'ambrogi,
Capri R Woolridge,
Carl Lee,
Carr,
Carrie E Thrasher,
Chloe Anne Leong,
Christopher J Lee,
Daniel C Geffin,
Daniel J Roberts,
Deborah Kleinfeld,
Edna J Hidalgo,
Edwards,
Elva M Ibarra,
Helen J Hamaoka,
Ingrid A Zambrana,
Ismael Garibay,
James C Yee,
Janice Wai,
Jazmine M Welcher,
Jeanne A Young,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer S King,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
Joseph M Willems,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Kevin P Foley,
Kristen E Szenderski,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Lee,
Leongc,
Lisa H Nakagawa,
Luis A Solorzano,
Macropolk,
Mark E Baldwin,
Mary C Acton,
Matthew K Wong,
Mcgrewp,
Michelle L Tripp,
Nympha V Florendo,
Peter E Baker,
Phung,
Quynh H Strandberg,
Roberta K Smith,
Robles,
Roger D Gawne,
Sean P Desbrow,
Seyyida Saterfield,
Sharon L Shane,
Shelley H Beausoleil,
State Agency,
Steve P Yost,
Steven B Chiu,
Timothy C Grome,
Tomanik'e C Banks,
William J Foust
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more